We may receive a commission on purchases made from links. When it comes to DIY tech, the Raspberry Pi is one of the most recognizable products out there. It's been around for more than a decade now, ...

Currently, the Python extension only supports “Run Selection/Line in Native Python REPL”. However, there is no built-in command to run the entire file in the Native Python REPL environment, similar to ...

FDA accepted Replimune’s resubmitted Biologics License Application for RP1 combined with Bristol Myers Squibb’s Opdivo to treat advanced melanoma The agency set April 10, 2026 as the decision deadline ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Following a ~39% drop in the previous session, Replimune (NASDAQ:REPL) shares continued to trade lower on Friday as J.P. Morgan downgraded the stock to Underweight from Neutral, citing further ...

On July 22, 2025, Replimune revealed that the FDA had issued a Complete Response Letter (CRL) for its Biologics License Application for RP1, a novel immunotherapy aimed at treating advanced melanoma.

Google's Gemini is now testing a new feature called "Projects." This will be similar to OpenAI's Project Feature for ChatGPT. With Projects, you can add files, documents or your code. Then, you can ...

In almost every organization I’ve advised, I’ve encountered the same problem: far too many projects, and far too few that truly matter. Harvard Business ...